Sanofi gets the green light to sell transplant-related drug Rezurock, in India
Sanofi Healthcare India receives marketing authorization for Rezurock, a new treatment for chronic graft-versus-host disease ...
Upgrading manufacturing quality standards for Indian pharma
This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.
money.rediff2d
Sanofi's cGVHD Drug Approved in India - Rezurock
Sanofi Healthcare India receives marketing authorization for Rezurock (Belumosudil), a new treatment for Chronic Graft-versus-Host Disease (cGVHD) in adults and adolescents.
Granules India gets USFDA’s nod for ADHD generic
Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...
Granules India Limited receives final approval from USFDA for its new drug
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...
'Skeletal editing' promises new, personalised drugs at fraction of cost — an Indian is pioneering it
At the University of Oklahoma, Prof. Indrajeet Sharma is leading a team of scientists that is working on a ‘skeletal editing’ technique that allows repurposing of existing drugs to treat different ...
FDA approves Ozempic for diabetes patients to cut kidney disease risk
The FDA approval is based on results from a trial investigating the effects of once-a-week Ozempic injections on major kidney ...